Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Bayer |
---|---|
Information provided by: | NIH AIDS Clinical Trials Information Service |
ClinicalTrials.gov Identifier: | NCT00002238 |
To evaluate the safety and efficacy of interferon beta (Betaseron) in AIDS and advanced AIDS related complex (ARC) patients receiving a reduced-dose zidovudine (AZT) regimen.
Condition | Intervention | Phase |
---|---|---|
HIV Infections |
Drug: Interferon beta-1b Drug: Zidovudine |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Double-Blind |
Official Title: | Phase III Randomized Double-Blind Placebo Controlled Study To Evaluate the Safety and Efficacy of Betaseron in AIDS and Advanced ARC Patients Receiving a Reduced-Dose AZT Regimen |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria
Concurrent Medication:
Allowed:
Patient must have:
Exclusion Criteria
Co-existing Condition:
Patients with the following are excluded:
Concurrent Medication:
Excluded:
Patients with the following are excluded:
Prior Medication:
Excluded within 30 days of study entry:
Active drug or alcohol abuse.
United States, California | |
Davies Med Ctr | |
San Francisco, California, United States, 94114 | |
Summitt Med Ctr / San Francisco Gen Hosp | |
Oakland, California, United States, 94609 | |
UCLA CARE Ctr | |
Los Angeles, California, United States, 90095 | |
USC School of Medicine / Norris Cancer Hosp | |
Los Angeles, California, United States, 90033 | |
Santa Clara Valley Med Ctr | |
San Jose, California, United States, 95128 | |
UCI Med Ctr | |
Orange, California, United States, 92668 | |
Alta Bates / Herrick Hosp | |
Berkeley, California, United States, 94704 | |
Cedars Sinai Med Ctr | |
Los Angeles, California, United States, 90048 | |
United States, District of Columbia | |
Dr William Davis | |
Washington, District of Columbia, United States, 20016 | |
George Washington Univ Med Ctr | |
Washington, District of Columbia, United States, 20037 | |
United States, Florida | |
Univ of South Florida | |
Tampa, Florida, United States, 33612 | |
United States, Georgia | |
AIDS Research Consortium of Atlanta | |
Atlanta, Georgia, United States, 30308 | |
United States, Illinois | |
Rush Presbyterian - Saint Luke's Med Ctr | |
Chicago, Illinois, United States, 60612 | |
Northwestern Univ Med School | |
Chicago, Illinois, United States, 60611 | |
United States, Maryland | |
Johns Hopkins Hosp | |
Baltimore, Maryland, United States, 21205 | |
United States, Massachusetts | |
Boston Med Ctr | |
Boston, Massachusetts, United States, 02118 | |
United States, New York | |
Beth Israel Med Ctr / Peter Krueger Clinic | |
New York, New York, United States, 10003 | |
Chelsea Village Med Ctr | |
New York, New York, United States, 10014 | |
Mem Sloan - Kettering Cancer Ctr | |
New York, New York, United States, 10021 | |
Dr Douglas Dieterich | |
New York, New York, United States, 10016 | |
United States, Ohio | |
Univ Hosp of Cleveland / Case Western Reserve Univ | |
Cleveland, Ohio, United States, 44106 | |
United States, Pennsylvania | |
Graduate Hosp | |
Philadelphia, Pennsylvania, United States, 19146 | |
Thomas Jefferson Med College | |
Philadelphia, Pennsylvania, United States, 19107 | |
Saint Christopher's Hosp for Children | |
Philadelphia, Pennsylvania, United States, 191341095 | |
United States, Texas | |
Univ TX Galveston Med Branch | |
Galveston, Texas, United States, 77550 |
Study ID Numbers: | 002A, TBO1-310188 |
Study First Received: | November 2, 1999 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00002238 |
Health Authority: | United States: Food and Drug Administration |
Drug Therapy, Combination Acquired Immunodeficiency Syndrome AIDS-Related Complex Zidovudine Interferon Type I |
Virus Diseases Sexually Transmitted Diseases, Viral HIV Infections Interferons Sexually Transmitted Diseases Acquired Immunodeficiency Syndrome |
Interferon beta-1b Interferon-beta Zidovudine AIDS-Related Complex Retroviridae Infections Immunologic Deficiency Syndromes |
Antimetabolites Anti-Infective Agents RNA Virus Infections Anti-HIV Agents Slow Virus Diseases Molecular Mechanisms of Pharmacological Action Immune System Diseases Immunologic Factors Antineoplastic Agents Physiological Effects of Drugs |
Adjuvants, Immunologic Enzyme Inhibitors Infection Antiviral Agents Pharmacologic Actions Reverse Transcriptase Inhibitors Anti-Retroviral Agents Therapeutic Uses Lentivirus Infections Nucleic Acid Synthesis Inhibitors |